GrowGen GRGW stock analysis

MAPS Pub­lic Ben­e­fit Cor­po­ra­tion, a Cal­i­for­nia biotech at­tempt­ing to bring MD­MA-as­sist­ed ther­a­py to mar­ket for men­tal health con­di­tions, said it has raised more than $100

Immunizing infants in their first respiratory syncytial virus (RSV) season with nirsevimab (Beyfortus) proved highly protective against severe disease, a case-control study showed. From October